Organization and Business - Narrative (Details) |
1 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 22, 2021
USD ($)
shares
|
Jan. 19, 2021
USD ($)
shares
|
Jul. 27, 2020
USD ($)
shares
|
Jun. 08, 2020
USD ($)
shares
|
May 15, 2020
USD ($)
|
Apr. 10, 2020
USD ($)
|
Apr. 02, 2020
USD ($)
shares
|
Mar. 27, 2020
USD ($)
shares
|
Mar. 20, 2020
USD ($)
shares
|
Mar. 31, 2021
USD ($)
|
Jan. 31, 2021
USD ($)
|
Apr. 30, 2020
USD ($)
|
Sep. 30, 2020
USD ($)
|
Sep. 30, 2021
USD ($)
patent
shares
|
Sep. 30, 2020
USD ($)
|
Dec. 31, 2020
shares
|
Aug. 19, 2021
shares
|
Aug. 18, 2021
shares
|
Aug. 11, 2021
shares
|
Aug. 10, 2021
shares
|
May 28, 2021
USD ($)
|
Jan. 07, 2021
shares
|
Jan. 06, 2021
shares
|
|
Debt Instrument [Line Items] | |||||||||||||||||||||||
Number of issued patents | patent | 18 | ||||||||||||||||||||||
Number of pending patents | patent | 7 | ||||||||||||||||||||||
Shares authorized amount (in shares) | shares | 5,681,817 | 13,333,334 | 21,500,000 | 12,222,222 | 1,400,285 | 3,115,001 | 3,931,428 | ||||||||||||||||
Sale of stock, consideration received on transaction | $ 6,250,000 | $ 8,000,000 | $ 10,750,000 | $ 5,500,000 | $ 245,050 | $ 545,125 | $ 688,000 | ||||||||||||||||
Proceeds from PPP and SBA loans | $ 0 | $ 1,258,900 | |||||||||||||||||||||
Common stock shares authorized (in shares) | shares | 200,000,000 | 100,000,000 | 200,000,000 | 150,000,000 | 200,000,000 | 150,000,000 | 150,000,000 | 100,000,000 | |||||||||||||||
Money market fund payments | $ 2,000,000 | ||||||||||||||||||||||
Interest-bearing account | $ 10,000,000 | ||||||||||||||||||||||
Net working capital | $ 13,100,000 | ||||||||||||||||||||||
Proceeds from sale of common stock, net | $ 14,300,000 | $ 16,500,000 | 13,137,500 | $ 16,432,190 | |||||||||||||||||||
Money Market Funds and Marketable Debt and Equity Securities | |||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||
Deposits | $ 9,000,000 | ||||||||||||||||||||||
Sales Agreement | |||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||
Sale of stock, maximum amount to be sold | $ 35,000,000 | ||||||||||||||||||||||
Commission fee, percent | 3.00% | ||||||||||||||||||||||
Paycheck Protection Program Loan | |||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||
Proceeds from PPP and SBA loans | $ 1,100,000 | $ 1,100,000 | |||||||||||||||||||||
Economic Injury Disaster Loan | |||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||
Proceeds from PPP and SBA loans | $ 149,900 | ||||||||||||||||||||||
Accounts Receivable | Customer Concentration Risk | Yahoo, Proper Media and Google | |||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||
Percentage of concentration risk | 44.00% | 38.40% |